Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02868554 · ClinicalTrials.gov registry record · NA
Accelerated Invisalign Therapy in Conjunction With Acceledent Aura
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02868554 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 34 participants.
The verdict
NCT02868554, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Purpose: The objective of this study is to investigate the effects of accelerated Invisalign and vibration therapy on rate of orthodontic tooth movement, activation of inflammation biomarkers as well as pain levels experienced by orthodontic patients during the initial 12 weeks of alignment. Participants: Up to 30 orthodontic patients of the University of North Carolina Orthodontic Residency Program will be recruited for this study. Patients older than 18 years old will be otherwise healthy subjects previously diagnosed with malocclusion. Procedures (methods): Each patient will be randomly allocated into either a control group or one of two intervention groups. Patients within the control group will receive standard Invisalign therapy without vibration. Patients within the intervention groups will receive accelerated Invisalign therapy with or without vibration. Patients receiving vibration therapy will utilize an AcceleDent Aura device which provides a light vibration at .25 Newtons (N) and 30 Hertz (Hz) frequency for twenty minutes daily. Three dimensional images of each subject's dentition will be recorded five times at 0 days, 4 days, 2 weeks, 6 weeks, and 12 weeks progress visits.
Interventions
- DEVICE AcceleDent Aura
- DEVICE Accelerated Invisalign therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02868554
The ClinicalTrials.gov registry entry for NCT02868554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AcceleDent Aura is the first listed.
NCT02868554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02868554 about?
NCT02868554 is a clinical study titled "Accelerated Invisalign Therapy in Conjunction With Acceledent Aura". Purpose: The objective of this study is to investigate the effects of accelerated Invisalign and vibration therapy on rate of orthodontic tooth movement, activation of inflammation biomarkers as well as pain levels experienced by orthodontic patients during the initial 12 weeks of alignment. Parti...
What is the current status of trial NCT02868554?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2016-08. Estimated completion is 2019-04-26.
What interventions are being tested in trial NCT02868554?
The interventions under investigation include: AcceleDent Aura (DEVICE), Accelerated Invisalign therapy (DEVICE).
Who is sponsoring clinical trial NCT02868554?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.